$84.20
▼ -1.5% Today
as of Sep 4, 16:55 ET
Last 30 days
Recent Press Releases & News
Transcat Acquires Southeastern Biomedical Associates For $12.8 Million
Transcat Expands its Biomedical Calibration Channel with the Acquisition of Southeastern Biomedical
Transcat to Participate in Jefferies, Lake Street and D.A. Davidson Investor Conferences in September
Overview
52-week range
$50
$100
68% of range
Avg surprise (last 3)
+18.1%
Avg reaction (last 2)
+2.3%
50% positive
Latest IV / EM
33%
EM ±5.2% · $85 · Sep 18
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Sat Jun 27, 2026 | Jun 2026 | $0.14 | — | — | — | — | financials |
| Tue May 26, 2026 | Mar/2026 | $0.56 | $0.51 | +9.8% | -12.5% | +4.7% | earnings |
| Sat Dec 27, 2025 | Dec 2025 | $-0.12 | — | — | — | — | financials |
| Sat Sep 27, 2025 | Sep 2025 | $0.14 | — | — | — | — | financials |
| Wed Aug 6, 2025 | Jun/2025 | $0.59 | $0.40 | +47.5% | — | — | earnings |
| Mon May 19, 2025 | Mar/2025 | $0.64 | $0.66 | -3.0% | — | -0.1% | earnings |
| Sat Dec 28, 2024 | Dec 2024 | $0.25 | — | — | — | — | financials |
| Sat Sep 28, 2024 | Sep 2024 | $0.35 | — | — | — | — | financials |
| Sat Jun 29, 2024 | Jun 2024 | $0.48 | — | — | — | — | financials |
| Sat Dec 23, 2023 | Dec 2023 | $0.38 | — | — | — | — | financials |
| Sat Sep 23, 2023 | Sep 2023 | $0.06 | — | — | — | — | financials |
| Sat Jun 24, 2023 | Jun 2023 | $0.38 | — | — | — | — | financials |
Financials
Income statement (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $93M | — | $84M | $82M | $82M | $76M | — | $67M |
| Cost of revenue | $62M | — | $59M | — | $56M | $51M | — | $47M |
| Gross profit | $31M | — | $25M | — | $27M | $26M | — | $20M |
| Operating income | $4M | — | $88,000 | — | $4M | $5M | — | $2M |
| Net income | $1M | — | $-1M | — | $1M | $3M | — | $2M |
| EPS (diluted) | $0.14 | — | $-0.12 | — | $0.14 | $0.35 | — | $0.25 |
Balance sheet (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $7M | $5M | $3M | — | $5M | $2M | $2M | $5M |
| Inventory | $15M | $14M | $13M | — | $13M | $15M | $14M | $14M |
| Total current assets | $96M | $92M | $81M | — | $86M | $80M | $78M | $77M |
| Total assets | $493M | $480M | $473M | — | $485M | $393M | $385M | $386M |
| Long-term debt | $110M | $100M | $100M | — | $112M | $33M | $31M | $39M |
| Total liabilities | $190M | $180M | $176M | — | $189M | $100M | $98M | $105M |
| Total equity | $303M | $301M | $297M | — | $295M | $293M | $287M | $281M |